医学
肝衰竭
肝切除术
入射(几何)
内科学
胃肠病学
肝病
重症监护医学
切除术
外科
光学
物理
作者
Yongchao Zeng,Hongda Ding,Ruoyao Zou
出处
期刊:Chinese Journal of Hepatobiliary Surgery
日期:2019-09-28
卷期号:25 (9): 711-715
标识
DOI:10.3760/cma.j.issn.1007-8118.2019.09.020
摘要
The prevention and treatment of posthepatectomy liver failure (PHLF) is a difficult problem for hepatectomy. PHLF is characterized by many risk factors, limited treatment methods and high mortality. There are many factors that lead to the insufficient quantity or quality of postoperative remnant liver cells, such as the comorbid conditions of patients, underlying disease of the liver, excessive liver resection and so on, which are increase the incidence of PHLF. However, the therapeutic treatment of PHLF is limited at present, the key to reduce the morbidity and mortality of PHLF lies in the accurate evaluation and screening of high-risk patients. This paper reviewed the relevant literature on the definition, risk factors and clinical prevention and treatment of posthepatectomy liver failure.
Key words:
Liver failure; Hepatectomy; Risk factors; Therapy
科研通智能强力驱动
Strongly Powered by AbleSci AI